The making
of a red
blood cell.
Erythropoiesis is the biological process through which erythroid progenitors develop into mature red blood cells, also called erythrocytes.
Controlled by molecular programs, erythropoietin and nutrient availability, this process provides the circulating cells required for oxygen transport.
Explore erythroid maturation ↓Erythropoiesis is the regulated production and maturation of red blood cells, transforming erythroid progenitors into hemoglobin-rich, enucleated erythrocytes.
From progenitor
to erythrocyte.
Red blood cells ultimately develop from hematopoietic stem cells through erythroid-competent progenitor populations. In classical descriptions, early erythroid progenitors include burst-forming unit–erythroid (BFU-E) cells followed by colony-forming unit–erythroid (CFU-E) cells.
BFU-E and CFU-E are functional progenitor categories originally defined by their colony-forming behavior in culture. CFU-E cells are more advanced erythroid progenitors and show strong dependence on erythropoietin signaling for survival and expansion.
Following these progenitor stages, recognizable nucleated erythroblasts undergo successive changes in cell size, chromatin condensation, cytoplasmic composition and hemoglobin content.
Progenitor commitment
Erythroid progenitors become increasingly committed to red blood cell development.
Terminal differentiation
Erythroblasts undergo regulated maturation, producing hemoglobin and reorganizing the nucleus and cytoplasm.
Enucleation
Late erythroblasts expel their condensed nuclei and become reticulocytes.
Final maturation
Reticulocytes progressively eliminate residual RNA and organelles, developing into mature erythrocytes.
The stages of
erythropoiesis.
Terminal erythroid maturation produces an ordered sequence of recognizable cell stages. These stages are identified by characteristics including nuclear appearance, cell size, cytoplasmic staining and hemoglobin accumulation.
| Stage | Nucleus | Cytoplasm | Key change |
|---|---|---|---|
| Proerythroblast | Large, relatively open chromatin | Basophilic | Earliest recognizable erythroblast |
| Basophilic erythroblast | Chromatin condensing | Strongly basophilic | Active protein synthesis |
| Polychromatic erythroblast | More condensed | Blue-gray to pinkish | Increasing hemoglobin |
| Orthochromatic erythroblast | Small, highly condensed | Predominantly pink | Preparatory steps to enucleation |
| Reticulocyte | Absent | Residual RNA and organelles | Further cellular remodeling |
| Mature erythrocyte | Absent | Hemoglobin-rich | Specialized gas transport |
Mature human erythrocytes are typically biconcave, flexible cells without nuclei. Their specialized structure supports efficient gas exchange and passage through small blood vessels.
The morphological sequence represents terminal erythroid maturation. It should not be confused with earlier BFU-E and CFU-E progenitor stages, which are generally defined through functional assays.
How does the body
sense the need for blood?
The rate of erythropoiesis is influenced by the body's oxygen requirements. In adults, the kidneys are the principal source of circulating erythropoietin (EPO), a hormone that supports erythroid progenitor survival and development.
Reduced oxygen availability can stabilize hypoxia-inducible transcription factors, especially HIF-2α in key EPO-producing cells. This promotes increased EPO expression and helps stimulate red blood cell production.
Tissue oxygen sensing detects inadequate oxygen delivery.
Oxygen-sensitive pathways increase erythropoietin expression.
EPO promotes survival and expansion of responsive progenitors.
Increased erythrocyte production can help restore oxygen delivery.
EPO signals through its receptor on appropriate erythroid cells, activating pathways that include JAK2 and STAT5. These pathways support progenitor survival and effective erythropoiesis.
EPO does not independently determine every stage of erythroid differentiation. Red cell production also requires transcriptional coordination, sufficient nutrients and a supportive marrow environment.
Building the cell's
oxygen machinery.
Erythrocytes carry oxygen through hemoglobin, a protein composed of globin chains and iron-containing heme groups. Efficient erythropoiesis therefore requires coordinated hemoglobin synthesis and an adequate iron supply.
Developing erythroblasts import iron largely through transferrin-mediated pathways. Intracellular iron is used in heme synthesis, which must remain coordinated with globin production.
Iron
Essential for the heme component of hemoglobin. Insufficient iron availability can limit red blood cell production.
Hepcidin
A liver-derived hormone that regulates iron availability by promoting degradation of the iron exporter ferroportin.
GATA1
A central transcription factor in erythroid differentiation and the regulation of erythroid gene programs.
KLF1
An erythroid transcription factor involved in globin expression, membrane maturation and other erythroid functions.
Inflammation can alter iron homeostasis, including through changes in hepcidin. This contributes to the complex regulation of erythropoiesis during chronic inflammatory states.
Erythropoiesis is
a collective process.
Developing erythroid cells interact with supportive populations in the bone marrow. Erythroblastic islands are cellular structures containing a central macrophage associated with surrounding erythroid precursors.
These associations participate in the organization and support of erythroid maturation. Macrophages can contribute to erythroblast interactions and the clearance of expelled nuclei.
The broader marrow environment provides growth factors, cell-contact signals and nutritional support. Effective red blood cell production depends on the coordination of intrinsic erythroid programs and external cues.
Explore the Bone Marrow Microenvironment ↗
When red cell
production changes.
Disturbances of erythropoiesis may contribute to anemia or increased red blood cell production. The underlying mechanisms vary considerably.
Iron deficiency, vitamin B12 or folate deficiency, kidney disease, inflammation, inherited hemoglobin disorders, and bone marrow disease can affect red cell production or survival.
Reticulocyte measurements are often used in hematologic evaluation because they provide information about recent marrow red cell output. Interpretation depends on the hemoglobin level, clinical situation and laboratory methods.
| Condition / Mechanism | Biological relationship | Research relevance |
|---|---|---|
| Iron deficiency | Insufficient iron for effective hemoglobin production | Iron metabolism and erythroid maturation |
| Chronic kidney disease | May reduce effective EPO production and involve other mechanisms | Hypoxia signaling and erythropoietin biology |
| Inflammation-associated anemia | Altered iron availability and erythroid regulation | Hepcidin, cytokines and iron restriction |
| Hemoglobin disorders | Inherited alterations of globin structure or production | Globin gene regulation and cell engineering |
| Marrow failure | Reduced hematopoietic production capacity | Stem cell function and marrow pathology |
Anemia has multiple potential causes, including blood loss and red cell destruction. Not every case of anemia is caused primarily by impaired erythropoiesis. Diagnosis requires clinical assessment and appropriate testing.
From red cell biology
to biotechnology.
Experimental erythropoiesis research combines erythroid culture systems, colony-forming assays, flow cytometry, gene-expression analysis and cellular imaging.
Research into erythroid progenitor expansion and maturation helps scientists understand abnormal red cell production and explore laboratory methods for generating erythrocyte-like cells.
Stem cell-derived erythroid systems are also used to study globin regulation, inherited hemoglobin disorders and the effects of genetic modifications on erythroid biology.
Producing fully mature, functional red blood cells at clinical scale remains technically challenging. Experimental systems must address maturation, enucleation, functionality, consistency and manufacturing requirements.
These challenges illustrate the broader connection between fundamental hematopoietic biology and emerging advances in regenerative medicine and cellular biotechnology.
Explore Research Methods ↗
A biological process
built around oxygen.
Erythropoiesis illustrates the connection between physiological demand, hormonal regulation, cellular differentiation and molecular synthesis.
Understanding this process supports research into anemia, inherited blood disorders, red cell manufacturing and the development of new cellular technologies.
Explore Blood Cell Lineages ↗